| T Wangdi Sherpa, MD | |
|
431 W Lincoln Ave, Myerstown, PA 17067-2328 | |
| (717) 866-5755 | |
| (717) 866-7120 |
| Full Name | T Wangdi Sherpa |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 31 Years |
| Location | 431 W Lincoln Ave, Myerstown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124021845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD065527L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Hospital | Lebanon, PA | Hospital |
| Reading Hospital | West reading, PA | Hospital |
| Milton S Hershey Medical Center | Hershey, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Myerstown Family Practice Pc | 4183617954 | 2 |
News Archive
The notion of offering a self-test for chlamydia via the Web - unique in the world - is the centerpiece of the dissertation that Daniel Novak will be defending at Umea University, Sweden, on March 3.
National Health Investors, Inc. announced today it has closed a $15 million purchase of four assisted living and memory care communities totaling 183 units in Louisiana and has leased those communities to Selah SeniorCare III and managed by Selah Management Group. The purchase price was funded from NHI's revolving credit facility.
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.
The Associated Press: "Overall spending on health care would rise as a result of legislation approved a week ago by the House, and billions of dollars in projected savings contained in the measure will be difficult to maintain, according to a report by a top official at the agency that oversees Medicare.
› Verified 8 days ago
| Entity Name | Myerstown Family Practice Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548311608 PECOS PAC ID: 4183617954 Enrollment ID: O20040407000073 |
News Archive
The notion of offering a self-test for chlamydia via the Web - unique in the world - is the centerpiece of the dissertation that Daniel Novak will be defending at Umea University, Sweden, on March 3.
National Health Investors, Inc. announced today it has closed a $15 million purchase of four assisted living and memory care communities totaling 183 units in Louisiana and has leased those communities to Selah SeniorCare III and managed by Selah Management Group. The purchase price was funded from NHI's revolving credit facility.
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.
The Associated Press: "Overall spending on health care would rise as a result of legislation approved a week ago by the House, and billions of dollars in projected savings contained in the measure will be difficult to maintain, according to a report by a top official at the agency that oversees Medicare.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| T Wangdi Sherpa, MD 431 W Lincoln Ave, Myerstown, PA 17067-2328 Ph: (717) 866-5755 | T Wangdi Sherpa, MD 431 W Lincoln Ave, Myerstown, PA 17067-2328 Ph: (717) 866-5755 |
News Archive
The notion of offering a self-test for chlamydia via the Web - unique in the world - is the centerpiece of the dissertation that Daniel Novak will be defending at Umea University, Sweden, on March 3.
National Health Investors, Inc. announced today it has closed a $15 million purchase of four assisted living and memory care communities totaling 183 units in Louisiana and has leased those communities to Selah SeniorCare III and managed by Selah Management Group. The purchase price was funded from NHI's revolving credit facility.
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.
The Associated Press: "Overall spending on health care would rise as a result of legislation approved a week ago by the House, and billions of dollars in projected savings contained in the measure will be difficult to maintain, according to a report by a top official at the agency that oversees Medicare.
› Verified 8 days ago
Laila Maher Younes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Perri Ave, Myerstown, PA 17067 Phone: 717-949-6581 Fax: 717-949-2816 | |
Ellen A Johnson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6 Perri Avenue, Myerstown, PA 17067 Phone: 717-949-6581 Fax: 717-949-2070 | |
Mrs. Julie A Header, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 36 W Main Ave, Myerstown, PA 17067 Phone: 717-376-3075 Fax: 844-252-3899 | |
Dr. Syed Muhammad Atif, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6 Perri Ave, Myerstown, PA 17067 Phone: 717-949-6581 Fax: 717-949-2816 | |
Bruce E Yeamans, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 431 W Lincoln Ave, Myerstown, PA 17067 Phone: 717-866-5755 Fax: 717-866-7120 | |
Daria Kovarikova, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6 Perri Ave, Myerstown, PA 17067 Phone: 717-949-6581 Fax: 717-949-2816 |